The novel metabolic bridges extending from liver to the bone: The liver-bone axis

Abstract

To the editor, We read with great interest the article by Ayyildiz et al. (1). We believe this study is valuable in terms of investigating the role of non-alcoholic fatty liver disease (NAFLD) in osteoporosis clinical practice. However, we have several suggestions to strengthen the study.